Metilfenidatın Dikkat Eksikliği Hiperaktivite Bozukluğu\'nda Uyku Bozukluğu Eş Tanısına Olumlu Etkileri

Abstract

Abstract Positive Effect of Methylphenidate on the Sleep Disorder Comorbidity in an Attention Deficit Hyperactivity Disorder Case Attention deficit hyperactivity disorder is one of the most common pscyhiatric disorders in childhood. Many recent studies have shown that sleep disorders are commonly encountered in children and adolescents with attention deficit hyperactivity disorder. Methylphenidate is used for the treatment of attention deficit hyperactivity disorder in children with high safety and tolerability. In this case report, the positive effect of methylphenidate on the comorbid sleep disorder in an adolescent with attention deficit hyperactivity disorder was discussed.

Keywords

• attention deficit hyperactivity disorder; sleep disorder; methylphenidate

Metilfenidatın Dikkat Eksikliği Hiperaktivite Bozukluğu'nda Uyku Bozukluğu Eş Tanısına Olumlu Etkileri

Abstract

Dikkat eksikliği hiperaktivite bozukluğu çocukluk çağında en sık görülen psikiyatrik bozukluklar arasında yer almaktadır. Son yıllarda yapılan çok sayıda araştırma dikkat eksikliği hiperaktivite bozukluğu olan çocuk ve ergenlerde uyku bozukluklarının sık olarak görüldüğünü göstermiştir. Metilfenidat dikkat eksikliği hiperaktivite bozukluğunun tedavisinde genel olarak yüksek bir güvenilirlik ve tolerabilite ile kullanılmaktadır. Bu olgu sunumunda metilfenidatın dikkat eksikliği hiperaktivite bozukluğu tanılı bir ergende uyku bozukluğu eş tanısına olan olumlu etkisi tartışılmıştır.

Keywords

• dikkat eksikliği hiperaktivite bozukluğu, uyku bozukluğu, metilfenidat

References

1. l. Findling RL. Evolution of the treatment of attention- defıcit/hyperactivity disorder in children: a review. Clin Ther2008;30(5):942-57.
2. Rappley MD. Safety issues in the use of methylphenidate. AnAmerican perspective. Drug Saf 1 997; 1 7(3): 143 -8.
3. Kuczenski R, Segal DS. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 1997;68(5):2032—7.
4. Yano M, Steiner H.Trends. Methylphenidate and cocaine: the same effects on gene regulation? Pharmacal Sei2007;28(11):588-96.
5. Yoon SY, J ain U, Shapiro C. Sleep in attention- deŞcit/hyperactivity disorder in children and adults: Past, present, and future. Sleep Med Rev 2012; 1 6(4):37 1 -88.
6. Cohen-Zion M, Ancoli-Israel S. Sleep in children with attention-deŞcit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention. Sleep MedRev 2004;8(5):379-402.
7. O'Brien LM, Holbrook CR, Mervis CB, Klaus CJ, Bruner JL, Raffıeld TJ, Rutherford J, Mehl RC, Wang M, Tuell A, Hume BC, Gozal D. Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-defıcit/hyperactivity disorder. Pediatrics 2003 ;1 1 1(3):554-63.
8. Corkum P, Moldofsky H, Hogg-Johnson S, Humphries T, Tannock R. Sleep problems in children with attentiondeficit/hyperactivity disorder: impact of subtype, comorbidity,and stimulant medication. J Am AeadChildAdolesePsychiat l999;38(10):1285-93.

9. O'Brien LM, Ivanenko A, Crabtree VM, Holbrook CR, Brunner JL, Klaus CJ, Gozal D. Sleep disturbances in children with attention deŞcit hyperactivity disorder. PediatrRes 2003;54(3):237-43.
10. Gruber R, Sadeh A, Raviv A. lnstability of sleep patterns in children with attention-deŞcit/hyperactivity disorder. JAm Acad Child Adolesc Psychiatry 2000;39(4):495- 501.
11. Silvestri R, Gagliano A, Arico I, Calarese T, Cedro C,
12. Kotagal S. Parasomnias in childhood. Sleep Med Rev
13. Meltzer LJ, Mindell JA. Sleep and sleep disorders in
14. Provini F, Tinuper P, Bisulli F, Lugaresi E. Arousal
15. Barkley RA, McMurray MB, Edelbrock CS, Robbins K.
16. Ring A, Stein D, Barak Y, Teicher A, Hadj ez J, Elizur A,
17. Efron D, Jarrnan F, Barker M. Side effects of
18. Stein MA, Blondis TA, Schnitzer ER, O'brien T, Fishkin J, Blackwell B, Szumowski E, Roizen NJ.
19. Tirosh E, Sadeh A, Munvez R, Lavie P. Effects of
20. Greenhill L, Puig-Antich J, Goetz R, Hanlon C, Davies
21. Chatoor 1, Wells KC, Conners CK, Seidel WT, Shaw D.
22. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams
23. A, Fabiano GA, Morrisey SM, Chronis AM, Forehand
24. Juszczak GR, Swiergiel AH. Serotonergic hypothesis of sleepwalking. Med Hypotheses 2005;64(1):28-32.
25. Stahl’s Essential Psychopharmacology: NeuroscientiŞc Basis and Practical Applications, Third Edition. Stephen M. Stahl. Cambridge University Press: New York, NY, 2008. 327-414.